Preclinical models to assess the immunogenicity of AAV vectors
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 342, 103722
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Unique Characteristics of AAV1, 2, and 5 Viral Entry, Intracellular Trafficking, and Nuclear Import Define Transduction Efficiency in HeLa CellsHuman Gene Therapy, 2011
- Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman PrimatesMolecular Therapy, 2011
- A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver DiseaseGastroenterology, 2011
- Adeno-associated Virus Vectors Serotype 2 Induce Prolonged Proliferation of Capsid-Specific CD8+ T Cells in MiceMolecular Therapy, 2011
- Cytotoxic-T-Lymphocyte-Mediated Elimination of Target Cells Transduced with Engineered Adeno-Associated Virus Type 2 Vector In VivoJournal of Virology, 2009
- Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In VivoJournal of Virology, 2009
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences, 2008
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- High-Level Transgene Expression in Nonhuman Primate Liver with Novel Adeno-Associated Virus Serotypes Containing Self-Complementary GenomesJournal of Virology, 2006